SARTORI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 7.175
AS - Asia 3.999
EU - Europa 3.010
SA - Sud America 645
AF - Africa 102
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 11
Totale 14.991
Nazione #
US - Stati Uniti d'America 7.026
SG - Singapore 1.395
CN - Cina 1.286
UA - Ucraina 607
BR - Brasile 563
HK - Hong Kong 524
DE - Germania 496
IT - Italia 478
PL - Polonia 345
FI - Finlandia 259
VN - Vietnam 228
GB - Regno Unito 215
TR - Turchia 165
RU - Federazione Russa 163
IE - Irlanda 136
CA - Canada 88
IN - India 87
FR - Francia 74
BD - Bangladesh 57
ID - Indonesia 57
SE - Svezia 54
ZA - Sudafrica 45
AU - Australia 40
MX - Messico 40
JP - Giappone 36
IQ - Iraq 33
ES - Italia 32
AR - Argentina 31
NL - Olanda 30
EE - Estonia 23
SA - Arabia Saudita 23
AT - Austria 15
EC - Ecuador 15
CZ - Repubblica Ceca 14
MY - Malesia 14
BE - Belgio 13
MA - Marocco 13
PK - Pakistan 13
AE - Emirati Arabi Uniti 10
EU - Europa 10
PY - Paraguay 9
BG - Bulgaria 8
EG - Egitto 8
IL - Israele 8
JO - Giordania 8
LT - Lituania 8
UZ - Uzbekistan 8
GR - Grecia 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
KE - Kenya 6
LK - Sri Lanka 6
MU - Mauritius 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
VE - Venezuela 6
NP - Nepal 5
PE - Perù 5
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
HN - Honduras 4
KG - Kirghizistan 4
KR - Corea 4
NG - Nigeria 4
AZ - Azerbaigian 3
BY - Bielorussia 3
ET - Etiopia 3
JM - Giamaica 3
KZ - Kazakistan 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CH - Svizzera 2
CM - Camerun 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
GH - Ghana 2
GY - Guiana 2
IR - Iran 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
PH - Filippine 2
TT - Trinidad e Tobago 2
YE - Yemen 2
AO - Angola 1
CI - Costa d'Avorio 1
CU - Cuba 1
DM - Dominica 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IM - Isola di Man 1
Totale 14.977
Città #
Fairfield 745
Singapore 720
Woodbridge 685
Ashburn 637
Hong Kong 516
Jacksonville 438
Houston 371
Chandler 364
Warsaw 340
Seattle 313
Cambridge 284
Beijing 278
Wilmington 251
Princeton 240
Ann Arbor 238
New York 208
Los Angeles 196
Helsinki 149
Nanjing 145
Dublin 136
Istanbul 136
Munich 113
The Dalles 111
Brescia 109
Dearborn 109
Shanghai 79
Moscow 78
Ho Chi Minh City 76
Des Moines 74
São Paulo 67
Nanchang 63
Redondo Beach 62
Dallas 58
Shenyang 58
Chicago 57
Hanoi 56
San Francisco 55
Changsha 54
Buffalo 53
Jinan 46
San Diego 45
Milan 44
Tianjin 42
London 38
Jakarta 37
Jiaxing 36
Hebei 34
Guangzhou 33
Denver 32
Toronto 31
Turku 31
Chennai 30
Montreal 29
Kunming 28
Tokyo 28
Brooklyn 26
Johannesburg 26
Santa Clara 25
Stockholm 25
Tallinn 23
Boston 22
Dong Ket 22
Poplar 22
Rome 22
Taizhou 22
Nuremberg 21
Verona 21
Orem 20
Atlanta 18
Hangzhou 18
Manchester 18
Zhengzhou 18
Frankfurt am Main 15
Lanzhou 15
Phoenix 15
Romola 15
Belo Horizonte 14
Campinas 14
Düsseldorf 14
Rio de Janeiro 14
Brussels 13
Charlotte 13
Dhaka 13
Falkenstein 13
Lappeenranta 12
Melbourne 12
Amsterdam 11
Lancaster 11
Mexico City 11
Ankara 10
Baghdad 10
Curitiba 10
Haiphong 10
Da Nang 9
Mumbai 9
Ningbo 9
Porto Alegre 9
Amman 8
Boardman 8
Delhi 8
Totale 9.980
Nome #
Preeclampsia and late fetal growth restriction 340
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 329
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 265
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 214
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 198
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 193
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 185
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 182
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 171
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 168
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 167
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 164
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 163
Analysis of the evolution in the management of endometrial cancer in Italy: a CTF study. 155
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study). 150
Prognostic factors in early-stage ovarian cancer. 149
Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause. 143
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 142
Early stage cervical cancer: adjuvant treatment in negative lymph node cases. 141
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities. 141
Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study). 140
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 138
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 136
The use of ultrasound-indicated cerclage or cervical pessary in asymptomatic twin pregnancies with a short cervix at midgestation 136
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 135
An Analysis of approaches to th treatment of endometrial cancer in western Europe: a CTF study 135
An analysis of approaches to the management of endometrial cancer in North America: a CTF study 134
Fetal anemia: Diagnosis and management 133
null 132
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 132
Identification of a new mutation in the SRY gene in a 46,XY woman with Swyer syndrome. 131
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia. 130
Twin reversed arterial perfusion sequence: current treatment options 129
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 128
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 126
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 124
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 124
Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. 123
Learning climate and quality of postgraduate training in gynecology and obstetrics should be assessed in italian training courses 123
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): Case Report and Systematic Literature Review 122
New development of the FIGO staging system. 122
Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors 122
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study) 121
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 121
Endometrial stromal sarcoma: analysis of treatment failures and survival 120
Bowel obstruction and survival in patients with advanced ovarian cancer: analysis of prognostic variables. 117
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 117
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. 114
Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. 114
The role of HE4 in ovarian cancer follow-up: a review. 112
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 112
Palliative care in advanced ovarian cancer patients with bowel obstruction 111
Retest positive for SARS‐CoV‐2 RNA of recovered pregnant women with COVID‐19 111
Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study 110
Patterns of Recurrence and Clinical Outcome of Patients with Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response after Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study 107
Analysis of failure after negative second look in patients with advanced ovarian cancer: an italian multicenter study 105
Management of borderline ovarian tumors: results of an italian multicenter study 105
Are surveillance procedures of clinical benefit forpatients treated for ovarian cancer?: A retrospective Italian multicentric study. 103
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. 103
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 103
Cancer in pregnancy: maternal and fetal implications on decision-making. 102
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 102
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 102
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 102
Follow-up strategies in gynecological oncology: searching appropriateness. 101
Adiponectin modulation by hyperandrogenism and insulin-resistance in polycystic ovary syndrome and normal women 97
An analysis of different approaches to ovarian cysts in Italy. 94
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 93
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 92
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 92
Cancer in Pregnancy: safety of chemotherapy on fetal outcome 90
Prenatal ultrasound diagnosis of cavitation of the ganglionic eminence 90
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 89
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 88
Surveillance procedures for patients with cervical carcinoma: a review of the literature. 87
Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks 87
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 87
A case of combined aortic bioprosthetic valve degeneration and patient-prosthesis mismatch during pregnancy: decision-making and implications after pregnancy. 86
A strange case of pleuritic pain in the third trimester of pregnancy 84
Clinical review of 55 cases of malignant ovarian germ cell tumors. 84
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis. 84
Clear cell degeneration associated with endometriosis of abdominal wall after cesarean section: A case report and systematic review of literature 84
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 84
Surveillance procedures for patients for cervical carcinoma: a review of the literature. 83
The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases 83
Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study. 83
Possible Coronavirus Disease 2019 Pandemic and Pregnancy: Vertical Transmission Is Not Excluded 83
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 82
Approcio anatomo clinico alla patologia dell'uteroin Diagnostica per immagini dell'apparato urogenitale 82
Folic acid supplementation in pregnancy: A matter of doses? 82
The prognostic value of antenatal ultrasound in cases complicated by fetal ovarian cysts 82
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patiants with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collqaborative Study 81
Surveillance procedures for patients treated for endometrial cancer: a review of the literature. 80
Early Intraperitoneal Transfusion for Fetal Hydrops Caused by Parvovirus B19 Infection 80
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta 80
Pre-chemoterapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who recwivwe a first-line taxane/platinum-based regimen: results of a multicenter retrospective italian study. 79
Pretreatment platele and hemoglobin levels are neither predictive non prognostic variables for patients with locally advanced ccervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study 77
Clear cell endometrial cancer: a CTF multicentre Italian study 77
Onset of idiopathic recurrent pericarditis during pregnancy: successful management with colchicine and intravenous immunoglobulins 77
Relationship between time interval from primary surgery to the start of taxane- plus platinum – based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: result of a multicenter retrospective italian study 76
Totale 12.089
Categoria #
all - tutte 82.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.137 0 0 0 0 0 194 79 189 194 238 165 78
2021/20221.062 71 195 20 48 19 30 93 83 62 99 96 246
2022/20231.038 152 37 46 49 88 260 12 116 153 5 62 58
2023/20241.156 84 27 92 103 45 178 73 55 296 29 20 154
2024/20252.921 19 93 79 393 285 288 270 101 323 192 576 302
2025/20263.439 610 676 338 783 672 360 0 0 0 0 0 0
Totale 15.197